Research peptides in South Africa: what SAHPRA's 2026 warning means
Peptides such as BPC-157 and TB-500 are sold online and in gyms with promises of faster healing, fat loss and younger skin. In May 2026 South Africa's medicines regulator, SAHPRA, warned that these products are unregistered and that selling them is illegal.
The short version
- Any product sold to treat, prevent or change how the body works must be registered with SAHPRA first. These peptides aren't.
- The human evidence that they work is thin, and there's no reliable way to know what's in an unregulated vial.
- If you're an athlete, BPC-157 is on the World Anti-Doping Agency's prohibited list.
- For injuries, weight and ageing, there are safer routes with better evidence. A doctor can take you through them.
What SAHPRA said
In a public warning published in May 2026, SAHPRA said it is seeing more unregistered peptide products sold online, in gyms and through informal channels. It listed the claims these products are usually sold with: weight loss, muscle growth, anti-ageing, injury recovery, better concentration and performance.
The warning names BPC-157, TB-500, Melanotan II, CJC-1295, Ipamorelin, PT-141, AOD-9604, Selank and Semax as examples of peptides being marketed illegally.
The legal point is simple. Under the Medicines and Related Substances Act 101 of 1965, a product meant to treat, prevent or alter how the body functions has to be registered with SAHPRA before it can be sold. Registration is how the regulator checks that a medicine is safe, works, and is made to a consistent quality. These products haven't been through that process.
Does "for research use only" change anything?
No. A label saying a vial is for research doesn't make it safe to inject, and it doesn't make it legal to sell to people for their own use. SAHPRA's warning is aimed at exactly these products, and it specifically warns against using them without medical supervision.
What the evidence says
BPC-157 is scientifically interesting, but after more than three decades of research, most of what's published comes from animal and cell studies, with only small pilot studies in people. A 2026 analysis from McMaster University also points out that much of the BPC-157 research traces back to a single research group, which is a reason for extra caution.
When someone feels better two weeks after starting a peptide, several things could explain it: time, the rehab they were doing anyway, expectation, and the natural ups and downs of an injury. Without proper trials, there's no way to separate those from a real effect.
Unregulated products add another problem. Without registration and quality control, the amount of active ingredient can vary, and products can be contaminated or mislabelled.
If you're an athlete
BPC-157 falls under the World Anti-Doping Agency's S0 category of non-approved substances, which are prohibited at all times. Using it, or a product that turns out to contain it, can lead to a ban.
What to do instead
- For an injury that isn't healing: a proper assessment, a rehab plan that loads the injury progressively, and enough protein and sleep. That's what our injury recovery programme is built on.
- For weight: doctor-led care, where any medication is registered, prescribed after a real consultation and dispensed by a pharmacy. See our weight management programme.
- For ageing well: the unglamorous things with the best evidence, such as strength training, blood pressure and blood sugar control, sleep and not smoking. See our longevity programme.
If a peptide therapy is ever registered in South Africa, a doctor will be able to prescribe it like any other medicine, dispensed by a pharmacy. Until then, we don't sell them, and we'd encourage you not to buy them.
If you've already used one
Stop, and tell your doctor what you used, how much and for how long, so they can check on you. You can report side effects to SAHPRA by emailing adr@sahpra.org.za. If you feel very unwell, get medical help straight away.